Concentrations of glutamate released following spinal cord injury kill oligodendrocytes in the spinal cord

被引:98
作者
Xu, GY [1 ]
Hughes, MG [1 ]
Ye, ZM [1 ]
Hulsebosch, CE [1 ]
McAdoo, DJ [1 ]
机构
[1] Univ Texas, Med Branch, Inst Marine Biomed, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA
关键词
AMPA/kainate receptors; excitotoxicity; glutamate; microdialysis; oligodendrocytes; spinal cord injury;
D O I
10.1016/j.expneurol.2004.01.029
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated in vivo in rats whether sufficient glutamate is released following spinal cord injury (SCI) to kill oligodendrocytes. Microdialysis sampling was used to establish the level of glutamate released (550 +/- 80 (muM) in the white matter during SCI. This glutamate concentration was administered into the spinal cords of other rats and the densities of oligodendrocytes remaining 24 and 72 h later determined by counting cells immunostained with the oligodendrocyte marker CC-1. Administration of ACSF, 4.0 mM glutamate (estimated resulting tissue exposure 500 muM) and 10.0 mM glutamate by microdialysis reduced oligodendrocyte density 22%, 57%, and 74%, respectively, relative to normal at 24 h post-exposure. Therefore, sufficient glutamate is released following SCI to damage white matter. Oligodendrocyte densities near the fiber track were not significantly different at 72 h from 24 h post-exposure, so most glutamate-induced oligodendrocyte death occurs within 24 h after exposure. Injecting the AMPA/kainate receptor blocker NBQX into the spinal cord during glutamate administration reduced the glutamate-induced decrease in oligodendrocyte density, evidence for AMPA/kainate receptor involvement in glutamate-induced oligodendrocyte death. This work directly demonstrates in vivo that following SCI glutamate reaches concentrations toxic to white matter and that AMPA/kainate receptors mediate this glutamate toxicity to oligodendrocytes. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:329 / 336
页数:8
相关论文
共 44 条
[1]   Apoptotic cells associated with wallerian degeneration after experimental spinal cord injury: A possible mechanism of oligodendroglial death [J].
Abe, Y ;
Yamamoto, T ;
Sugiyama, Y ;
Watanabe, T ;
Saito, N ;
Kayama, H ;
Kumagai, T .
JOURNAL OF NEUROTRAUMA, 1999, 16 (10) :945-952
[2]  
Agrawal SK, 1997, J NEUROSCI, V17, P1055
[3]  
Bhat RV, 1996, GLIA, V17, P169
[4]   AXONAL PHYSIOLOGY OF CHRONIC SPINAL-CORD INJURY IN THE CAT - INTRACELLULAR-RECORDING INVITRO [J].
BLIGHT, AR .
NEUROSCIENCE, 1983, 10 (04) :1471-1486
[5]   MORPHOMETRIC ANALYSIS OF EXPERIMENTAL SPINAL-CORD INJURY IN THE CAT - THE RELATION OF INJURY INTENSITY TO SURVIVAL OF MYELINATED AXONS [J].
BLIGHT, AR ;
DECRESCITO, V .
NEUROSCIENCE, 1986, 19 (01) :321-+
[6]   Oligodendroglial apoptosis occurs along degenerating axons and is associated with Fas and p75 expression following spinal cord injury in the rat [J].
Casha, S ;
Yu, WR ;
Fehlings, MG .
NEUROSCIENCE, 2001, 103 (01) :203-218
[7]  
Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO
[8]  
2-9
[9]   Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys [J].
Crowe, MJ ;
Bresnahan, JC ;
Shuman, SL ;
Masters, JN ;
Beattie, MS .
NATURE MEDICINE, 1997, 3 (01) :73-76
[10]   PHARMACOTHERAPY IN SPINAL-CORD INJURY - A CRITICAL-REVIEW OF RECENT DEVELOPMENTS [J].
FADEN, AI .
CLINICAL NEUROPHARMACOLOGY, 1987, 10 (03) :193-204